Find and Pitch Jounalists, Get Your Story Covered

Tags: Carl Harris, Construction, Housing construction, housing market data, Housing Starts, MLSNewsFeed, NAHB, National Association of Home Builders, Premier, Real Estate Data, Robert Dietz, Single Family Homes Daily, MedCity Influencers, Payers, Providers ai startups venture

	Profile	Recent Articles on Subject
1	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma - 3 days ago 'Very Clear Signal' That Survival Improved With Addition of Durvalumab in SCLC - 6 months ago Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patients - 12 months ago
2	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: The Persistent Association Between Obesity and Breast Cancer Outcomes - 15 days ago SABCS 2024: Anthracyclines May Improve Survival in High-Risk Breast Cancer, But Risks Must Be Weighed - 18 days ago SABCS 2024: Risk-Reducing Surgeries Linked to Improved Survival in Young BRCA Carriers with Breast Cancer - 20 days ago FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer - 9 months ago Durvalumab Shows Improvements in Overall Survival, Progression-Free Survival for Small Cell Lung Cancer - 9 months ago Adagrasib Meets Primary Endpoint Among Individuals with KRAS G12C-Mutated Locally Advanced or Metastatic NSCLC - 9 months ago Osimertinib With Chemotherapy Could Aid Overall Survival for NSCLC - 9 months ago Researchers Assess Second Primary Lung Cancer Among Survivors Without Smoking History - 12 months ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Better Quality of Life With RT vs Endocrine Therapy in Older Breast Cancer Patients - 18 days ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 4 months ago No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer - 4 months ago Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma - 4 months ago Trial Questions Role of Dual Immunotherapy in First-Line NSCLC - 4 months ago Mediterranean Diet Tied to Lower Mortality Risk in Cancer Survivors - 6 months ago Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? - 9 months ago Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials - 9 months ago Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - 11 months ago Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC - about 1 year ago Emergency Liver Transplant Effective for Severe Acute-on-Chronic Liver Failure - about 1 year ago AKI Response Tied to Improved Survival for Patients Waiting on Liver Transplant - about 1 year ago T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancers - about 1 year ago Reduced Mortality Seen in Cancer Survivors Who Meet Exercise Guidelines - over 1 year ago Delaying Esophageal Cancer Surgery After Neoadjuvant CRT Fails in Trial - over 1 year ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - 3 months ago
5	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Is New Standard of Care for High-Risk Early-Stage TNBC - 4 months ago Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 4 months ago Addressing Disparities in Long-Term Survivorship and Quality of Life for Young Patients With Breast Cancer - 4 months ago Advancements in HER2+ Breast Cancer Treatment: Insights From the HER2CLIMB-02 Trial - 11 months ago Use of Recurrence Score Combined With Clinical, Genetic Factors Improves Prognostic Ability in HR+/ HER2– Early Breast Cancer - about 1 year ago
6	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	EVT on Large Core Strokes: Sobering Results for the Oldest Old - 5 months ago Intravascular Imaging-Guided PCI Reaches a Turning Point With Survival, MI Benefits - 10 months ago
7	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	Prolonged Beta-Lactam Dosing Boosts Survival in Sepsis, Septic Shock - 7 months ago Large-Core Strokes Do Better Long-Term With Thrombectomy - 11 months ago
8	Clare Watson Science Alert Science writer. Wollongong, Dharawal country sciencefreelance journalism	A Healthy Lifestyle Could Offset Genetic Risk For Early Death by a Hopeful 62% - 8 months ago
9	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	Exact Sciences’ cancer blood test achieves 51% sensitivity in prospective trial - 9 months ago
10	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: About half of cancer drugs given accelerated approval don’t show improved survival or quality of life - 9 months ago

Journalists covering overall survival